TrialThe oncologist2023

Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.

Richard T Penson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.